Nomogram predicting survival as a selection criterion for postmastectomy radiotherapy in patients with T1 to T2 breast cancer with 1 to 3 positive lymph nodes

被引:18
|
作者
Tang, Yu [1 ,2 ]
Zhang, Yu-Jing [3 ]
Zhang, Na [4 ]
Shi, Mei [5 ]
Wen, Ge [6 ]
Cheng, Jing [7 ]
Wang, Hong-Mei [8 ]
Liu, Min [9 ]
Wang, Xiao-Hu [10 ]
Guo, Qi-Shuai [11 ]
Wu, Hong-Fen [12 ]
Ma, Chang-Ying [13 ]
Jin, Jing [1 ,2 ]
Liu, Yue-Ping [1 ,2 ]
Song, Yong-Wen [1 ,2 ]
Fang, Hui [1 ,2 ]
Ren, Hua [1 ,2 ]
Wang, Shu-Lian [1 ,2 ]
Li, Ye-Xiong [1 ,2 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, State Key Lab Mol Oncol, Natl Clin Res Ctr Canc,Canc Hosp, Panjiayuan Nanli 17, Beijing 100021, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Dept Radiat Oncol, Natl Clin Res Ctr Canc,Canc Hosp, Panjiayuan Nanli 17, Beijing 100021, Peoples R China
[3] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, Dept Radiat Oncol, State Key Lab Oncol South China,Canc Ctr, Guangzhou, Peoples R China
[4] China Med Univ, Liaoning Canc Hosp & Inst, Canc Hosp, Dept Radiat Oncol, Shenyang, Peoples R China
[5] Fourth Mil Med Univ, Xijing Hosp, Dept Radiat Oncol, Xian, Peoples R China
[6] Guangzhou Med Univ, Dept Radiat Oncol, Affiliated Hosp 3, Guangzhou, Peoples R China
[7] Huazhong Univ Sci & Technol, Dept Breast Oncol, Union Hosp, Tongji Med Coll, Wuhan, Peoples R China
[8] Southern Med Univ, Nanfang Hosp, Dept Radiat Oncol, Guangzhou, Peoples R China
[9] First Hosp Jilin Univ, Dept Radiat Oncol, Changchun, Peoples R China
[10] Gansu Canc Hosp, Dept Radiat Oncol, Lanzhou, Peoples R China
[11] Chongqing Univ, Chongqing Canc Hosp, Chongqing Canc Inst, Dept Radiat Oncol,Canc Hosp, Chongqing, Peoples R China
[12] Jilin Canc Hosp, Dept Radiat Oncol, Changchun, Peoples R China
[13] First Hosp Qiqihaer, Dept Radiat Oncol, Qiqihar, Peoples R China
关键词
breast neoplasm; mastectomy; N1; nomogram; radiotherapy; LOCOREGIONAL RECURRENCE RISK; POSTOPERATIVE RADIOTHERAPY; PREMENOPAUSAL WOMEN; CLINICAL ONCOLOGY; AMERICAN SOCIETY; MASTECTOMY; CHEMOTHERAPY; MULTICENTER; IRRADIATION; RADIATION;
D O I
10.1002/cncr.32963
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background The role of postmastectomy radiotherapy (PMRT) in women with pT1-T2N1 breast cancer is controversial. The authors developed a nomogram that was predictive for overall survival (OS) and identified patients who derived no benefit from PMRT. Methods The authors retrospectively evaluated 4869 patients with pT1-T2N1 breast cancer who were treated with mastectomy between 2000 and 2014 in 11 Chinese hospitals. Rates of locoregional recurrence and distant metastasis were calculated using competing risk analysis, and disease-free survival and OS rates were calculated using the Kaplan-Meier method. Based on the risk factors identified from Cox regression analysis in 3298 unirradiated patients, a nomogram predicting OS was developed. The benefit of PMRT was evaluated in different risk groups stratified by the nomogram model. Results After a median follow-up of 65.9 months, the 5-year OS, disease-free survival, locoregional recurrence, and distant metastasis rates were 93.3%, 84.3%, 5.2%, and 8.3%, respectively. A total of 1571 patients (32.3%) underwent PMRT. On multivariable analyses, PMRT was found to increase OS significantly (hazard ratio, 0.61;P = .002). An OS prediction nomogram evaluated the effect of age; tumor location; tumor size; positive lymph node ratio; estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 status; and treatment with trastuzumab. Based on nomogram scores, the entire patient cohort was classified into 3 risk groups. PMRT significantly improved the OS of patients in the intermediate-risk (P < .001) and high-risk groups (P = .004), but not in the low-risk group (P = .728). Conclusions The authors developed a nomogram that is predictive of OS among women with pT1-T2N1 breast cancer after mastectomy. This nomogram may help to select a subgroup of patients with a good prognosis who will not benefit from PMRT.
引用
收藏
页码:3857 / 3866
页数:10
相关论文
共 50 条
  • [1] Predicting loco-regional recurrence risk in T1, T2 breast cancer with 1-3 positive axillary nodes postmastectomy: Development of a predictive nomogram
    Wadasadawala, T.
    Kannan, S.
    Gudi, S.
    Rishi, A.
    Budrukkar, A.
    Parmar, V
    Shet, T.
    Desai, S.
    Gupta, S.
    Badwe, R.
    Sarin, R.
    INDIAN JOURNAL OF CANCER, 2017, 54 (01) : 352 - 357
  • [2] Selection Criteria for Postmastectomy Radiotherapy in T1-T2 Tumors with 1 to 3 Positive Lymph Nodes
    Moo, Tracy Ann
    McMillan, Robert
    Lee, Michele
    Stempel, Michelle
    Patil, Sujata
    Ho, Alice
    El-Tamer, Mahmoud
    ANNALS OF SURGICAL ONCOLOGY, 2013, 20 (10) : 3169 - 3174
  • [3] Use of Postmastectomy Radiotherapy and Survival Rates for Breast Cancer Patients with T1-T2 and One to Three Positive Lymph Nodes
    Huo, Dezheng
    Hou, Ningqi
    Jaskowiak, Nora
    Winchester, David J.
    Winchester, David P.
    Yao, Katharine
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 (13) : 4295 - 4304
  • [4] Role of postmastectomy radiation therapy in breast cancer patients with T1-2 and 1-3 positive lymph nodes
    Cihan, Yasemin Benderli
    Sarigoz, Talha
    ONCOTARGETS AND THERAPY, 2016, 9 : 5587 - 5595
  • [5] Impact of postmastectomy radiation therapy in T1-2 breast cancer patients with 1-3 positive axillary lymph nodes
    Yin, Hang
    Qu, Yuanyuan
    Wang, Xiaoyuan
    Ma, Tengchuang
    Zhang, Haiyang
    Zhang, Yu
    Li, Yang
    Zhang, Siliang
    Ma, Hongyu
    Xing, Enkang
    Liu, Xueying
    Xu, Qingyong
    ONCOTARGET, 2017, 8 (30) : 49564 - 49573
  • [6] Prognostic factors for breast cancer patients with T1–2 tumors and 1–3 positive lymph nodes and the role of postmastectomy radiotherapy in these patients
    Jia-ming Zhao
    Qi An
    Chao-nan Sun
    Yu-bing Li
    Zi-lan Qin
    Hong Guo
    Xue Zeng
    Yao-tian Zhang
    Lin-lin Wei
    Ning Han
    Shi-chen Sun
    Na Zhang
    Breast Cancer, 2021, 28 : 298 - 306
  • [7] Whether adjuvant radiotherapy is desired for postmastectomy patients with T1-T2 tumors and 1-3 positive axillary lymph nodes who received modern systemic therapy?
    Lai, Shih-Fan
    Huang, Chiun-Sheng
    Kuo, Sung-Hsin
    TRANSLATIONAL CANCER RESEARCH, 2019, 8 : S110 - S114
  • [8] Real-world impact of postmastectomy radiotherapy in T1-2 breast cancer with one to three positive lymph nodes
    Li, Feng-Yan
    Lian, Chen-Lu
    Lei, Jian
    Wang, Jun
    Hua, Li
    He, Zhen-Yu
    Wu, San-Gang
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (07)
  • [9] Prognostic factors for breast cancer patients with T1-2 tumors and 1-3 positive lymph nodes and the role of postmastectomy radiotherapy in these patients
    Zhao, Jia-ming
    An, Qi
    Sun, Chao-nan
    Li, Yu-bing
    Qin, Zi-lan
    Guo, Hong
    Zeng, Xue
    Zhang, Yao-tian
    Wei, Lin-lin
    Han, Ning
    Sun, Shi-chen
    Zhang, Na
    BREAST CANCER, 2021, 28 (02) : 298 - 306
  • [10] Most Breast Cancer Patients with T1-2 Tumors and One to Three Positive Lymph Nodes Do Not Need Postmastectomy Radiotherapy
    Muhsen, Shirin
    Moo, Tracy-Ann
    Patil, Sujata
    Stempel, Michelle
    Powell, Simon
    Morrow, Monica
    El-Tamer, Mahmoud
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 (07) : 1912 - 1920